POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU

Clinical trial NCT05953688 · TERMINATED

Trial details

NCT number: NCT05953688
Sponsor: Alumis Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Uveitis Posterior Non-Infectious Uveitis, Intermediate Noninfectious Panuveitis

Start date: 2023-06-14
Primary completion: 2024-08-13
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.